XERIANT, INC. financials

XERI CIK 0001481504

Source: EDGAR filings · Built 2026-10-01T00:19:55Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow -794.76K -1.29M -1.43M -1.18M -6.95M -1.01M
EBITDA -1.06M -1.36M -1.90M -2.05M -11.00M -2.20M
Working Capital -4.90M — -8.66M -6.68M -3.07M 677.26K
Net Debt 399.43K 1.81M 5.20M 5.88M -674.78K -620.54K
Return on Equity (ROE) -19.50% 28.28% 53.94% 187.11% 449.11% -293.13%
Return on Assets (ROA) 394.38% -2414.13% -435.21% -4246.48% -1047.61% -235.93%
Current Ratio 0.02× — 0.07× 0.01× 0.26× 3.26×
Debt-to-Equity -0.24× -0.32× -1.02× -1.57× -0.13× 0.37×
Effective Tax Rate 3.89% 0.00% 0.00% — — —
Cash Conversion Ratio -2.02× 0.78× 0.46× 0.17× 0.52× 0.37×
Accruals Ratio 11.90× -5.25× -2.35× -35.44× -5.02× -1.48×
CapEx Coverage -263.92× -731.27× — -457.42× -346.54× —
Free Cash Flow Per Share $-0.00 $-0.00 $-0.00 — $-0.02 $-0.00

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Research and Development Expense 99.91K 69.27K 196.42K 0 5.27M 373.11K
Operating Expenses 1.06M 1.37M 1.91M 2.05M 11.01M 2.20M
Operating Income (Loss) -1.06M -1.37M -1.91M -2.05M -11.01M -2.20M
Income Tax Expense (Benefit) 15.88K 0 0 — — 0
Net Income (Loss) Attributable to Parent 392.28K -1.65M -3.10M -7.10M -13.30M -2.70M
Earnings Per Share, Basic $0.00 $0.00 — — $-0.05 $-0.01
Weighted Average Number of Shares Outstanding, Basic — — — — 345.16M 225.50M
Earnings Per Share, Diluted $0.00 $0.00 $-0.01 — $-0.05 $-0.01
Weighted Average Number of Shares Outstanding, Diluted 1.73B 620.88M 443.26M — 345.16M 225.50M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value — — — — — 962.54K
Assets, Current 91.21K 56.68K 664.21K 66.15K 1.07M 976.32K
Assets 99.47K 68.22K 713.00K 167.12K 1.27M 1.15M
Liabilities, Current 4.99M 8.77M 9.33M 6.75M 4.14M 299.06K
Liabilities 4.99M 8.77M 9.33M 6.79M 4.23M 440.22K
Stockholders' Equity Attributable to Parent -2.01M -5.82M -5.75M -3.79M -2.96M 921.99K
Common Stock, Shares, Outstanding 1.06B 695.75M 524.85M 389.43M 365.24M 292.82M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities -791.76K -1.29M -1.43M -1.17M -6.93M -1.01M
Payments to Acquire Property, Plant, and Equipment 3.00K 1.76K 0 2.57K 19.99K 0
Net Cash Provided by (Used in) Investing Activities -3.00K -1.76K -8.16K -200.13K -135.35K 0
Net Cash Provided by (Used in) Financing Activities 837.50K 682.00K 2.03M 370.00K 7.17M 1.94M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (XERI CIK 0001481504), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

OKYO

OKYO Pharma Limited

ZDGE

ZEDGE, INC.

FBYD

Falcon’s Beyond Global, Inc.